Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

2.3K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.3K
EPS and iPS Cells in Disease Research01:21

EPS and iPS Cells in Disease Research

3.5K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
3.5K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

1.3K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.3K
Neural Regulation01:37

Neural Regulation

44.6K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
44.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cognitive structure and progression in Parkinson's disease: insights from a tablet-based assessment.

Scientific reports·2026
Same author

Comparing Stakeholders' Perspectives on Parkinson Disease Management and Digital Technologies: Exploratory International Survey.

JMIR formative research·2026
Same author

Phenotypic spectrum of FGF14-related late-onset ataxia: predominant tremor and cognitive decline as key features of SCA27A.

Journal of neurology·2026
Same author

Alzheimer's Disease Co-Pathology and Cognitive Impairment in Amyotrophic Lateral Sclerosis.

Annals of neurology·2026
Same author

Impact of Plasma p-tau181 on Cognition, Motor Phenotypes, and Disease Course in ALS.

Annals of clinical and translational neurology·2026
Same author

CSF alpha-Synuclein Seed Amplification Assay results in routine clinically collected samples.

Journal of Parkinson's disease·2026

Related Experiment Video

Updated: Mar 22, 2026

The 6-hydroxydopamine Rat Model of Parkinson's Disease
08:10

The 6-hydroxydopamine Rat Model of Parkinson's Disease

Published on: October 27, 2021

13.4K

Cellular models for Parkinson's disease.

Björn H Falkenburger1,2, Theodora Saridaki3, Elisabeth Dinter3

  • 1Department of Neurology, RWTH University Aachen, Aachen, Germany. bfalkenburger@ukaachen.de.

Journal of Neurochemistry
|April 20, 2016
PubMed
Summary

Cellular models are crucial for Parkinson's disease research, replicating dopaminergic neuron loss and alpha-synuclein aggregates. This guide helps researchers choose appropriate models and techniques for studying Parkinson's disease.

Keywords:
Dementia with Lewy bodiesFRETnon-motor symptoms

More Related Videos

Applying the RatWalker System for Gait Analysis in a Genetic Rat Model of Parkinson's Disease
04:08

Applying the RatWalker System for Gait Analysis in a Genetic Rat Model of Parkinson's Disease

Published on: January 18, 2021

3.5K
Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease
08:09

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease

Published on: January 7, 2014

8.0K

Related Experiment Videos

Last Updated: Mar 22, 2026

The 6-hydroxydopamine Rat Model of Parkinson's Disease
08:10

The 6-hydroxydopamine Rat Model of Parkinson's Disease

Published on: October 27, 2021

13.4K
Applying the RatWalker System for Gait Analysis in a Genetic Rat Model of Parkinson's Disease
04:08

Applying the RatWalker System for Gait Analysis in a Genetic Rat Model of Parkinson's Disease

Published on: January 18, 2021

3.5K
Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease
08:09

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease

Published on: January 7, 2014

8.0K

Area of Science:

  • Neuroscience
  • Cell Biology
  • Biomedical Research

Background:

  • Parkinson's disease (PD) research necessitates effective cellular models.
  • Current models mimic key PD features: dopaminergic neuron degeneration and alpha-synuclein aggregation.
  • Cellular models offer advantages over in vivo studies but require careful selection.

Purpose of the Study:

  • To guide researchers in selecting suitable cellular models for Parkinson's disease studies.
  • To detail the strengths and weaknesses of commonly used cell types for modeling PD aspects.
  • To provide insights into strategies for inducing and measuring alpha-synuclein aggregates.

Main Methods:

  • Review of commonly used cell types for Parkinson's disease modeling.
  • Analysis of cellular models for dopaminergic neuron degeneration.
  • Description of techniques for inducing and measuring alpha-synuclein aggregates, including fluorescent methods.

Main Results:

  • Lund human mesencephalic cells and primary neurons are highlighted for modeling dopaminergic neuron loss.
  • Non-dopaminergic cells are proposed for modeling non-motor symptoms.
  • Fluorescent techniques are effective for studying alpha-synuclein aggregates.

Conclusions:

  • Cellular models are indispensable tools for advancing Parkinson's disease therapeutics.
  • Careful selection of cell types and techniques is vital for accurate disease modeling.
  • This article serves as a resource for researchers utilizing cellular models in PD studies.